NEW YORK, NY / ACCESSWIRE / February 10, 2016 / Today, we draw your attention to the HealthCare Sector. With Zika Virus on the front page of every major news source it is no wonder HealthCare stocks are on top of everyone's radar. Join us today at valuableinvestment.com to learn how our research team is trading this sector. Is this the Bear Market pundits have been calling for? Or is this broad market decline presenting you with a chance to buy world class companies at a discount? Find out more at:

http://valuableinvestment.com

Visit us at valuableinvestment.com to learn how we are helping our members trade the HealthCare.

ValuableInvestment.com has trade alerts on these stocks: Valeant Pharmaceuticals International Inc. (NYSE: VRX), Alkermes PLC (NASDAQ: ALKS), AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), and IDEXX Laboratories Inc. (NASDAQ: IDXX). Register now and join other shareholders on these companies who as our members are already taking full benefit of our trade alerts at:

http://www.valuableinvestment.com/freealerts

On Tuesday, February 09, 2016, the NASDAQ Composite ended at 4,268.76, down 0.35%, the Dow Jones Industrial Average edged 0.08% lower, to finish the day at 16,014.38, and the S&P 500 closed at 1,852.21, down 0.07%. Shares in Valeant Pharmaceuticals International Inc. ended the session 2.99% lower at $86.95. The stock reported a trading volume of 6.73 million shares, below its three months average volume of 10.24 million shares. Shares of the company traded at a PE ratio of 49.12. Valeant Pharmaceuticals International Inc.'s shares have advanced 6.33% in the previous three months, but it has declined 4.51% in the last one month. The company is trading 10.00% below its 50-day moving average and 50.49% below its 200-day moving average. Moreover, shares of Valeant Pharmaceuticals International Inc. have a Relative Strength Index (RSI) of 44.17. Free alert on VRX can be accessed at:

http://valuableinvestment.com/VRX

Alkermes PLC's stock lost 1.32%, to close the day at $29.06. The stock recorded a trading volume of 1.60 million shares, above its three months average volume of 1.39 million shares. The company's shares are trading 53.57% below their 50-day moving average. Additionally, Alkermes PLC has an RSI of 18.20. Sign up and activate your free alert on ALKS at:

http://valuableinvestment.com/ALKS

On Tuesday, shares in AMAG Pharmaceuticals Inc. recorded a trading volume of 0.89 million shares, lower than their three months average volume of 1.03 million shares. The stock ended the day 1.58% higher at $23.13. Shares of the company traded at a PE ratio of 4.96. The company is trading below its 50-day and 200-day moving averages by 11.39% and 52.23%, respectively. Furthermore, shares of AMAG Pharmaceuticals Inc. have an RSI of 44.55. Register for free on ValuableInvestment.com and activate your trade alert on AMAG at:

http://valuableinvestment.com/AMAG

IDEXX Laboratories Inc.'s stock finished Tuesday's session 1.57% lower at $68.49. A total of 0.67 million shares were traded, which was below its three months average volume of 0.70 million shares. The company's shares are trading below their 50-day and 200-day moving averages by 1.88% and 2.18%, respectively. IDEXX Laboratories Inc.'s stock traded at a PE ratio of 33.41 and has an RSI of 48.00. IDXX free trade alert is just a click away at:

http://valuableinvestment.com/IDXX

--

About ValuableInvestment.com:

Valuable Investment was founded in 2006 and has been successfully alerting investors and shareholders of the most profitable ways to earn a living on Wall Street. A decade is a very long time so we must be doing something right. We encourage everyone to come and try our strategy and see how we have been changing the foundation of research for years.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY

ValuableInvestment.com, the Author, the Reviewer, and the Sponsor (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither valuableinvestment.com nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://valuableinvestment.com

RESTRICTIONS

ValuableInvestment.com is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press@valuableinvestment.com

SOURCE: ValuableInvestment.com